4 recruiting, 3 completed. 6 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Recruiting 4, Completed 2 |
| Phase 2 | 4 | Recruiting 3, Completed 1 |
Follow Panitumumab IRDye 800: new trials by email Literature Review of Panitumumab IRDye 800 trials Research Report on Panitumumab IRDye 800
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer Panitumumab IRDye 800 - HNSCC, HNSCC,Larynx, Pharynx and Oral Cavity | Phase 1 | Recruiting | Vanderbilt-Ingram Cancer Center | 70 | 2025-04-17 | 2026-08-03 |
| Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head&Neck Cancer Panitumumab-IRDye800, Lymphoseek - Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck (SCCHN) | Phase 2 | Completed | Eben Rosenthal | 3 | 2019-08-01 | 2022-11-10 |
| Panitumumab-IRDye800 and 89Zr-Panitumumab in Identifying Metastatic Lymph Nodes in Patients With Squamous Cell Head and Neck Cancer Panitumumab-IRDye800, 89-Zirconium (Zr-89) Panitumumab, Pinpoint IR IR9000 fluorescence imaging system (FIS) - Squamous Cell Carcinoma of the Head and Neck, Carcinoma of the Head and Neck | Phase 1 | Completed | Andrei Iagaru | 14 | 2019-01-07 | 2023-05-19 |
| Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery Near-Infrared Fluorescence Imaging, Panitumumab-IRDye800, Pharmacokinetic Study - Lung Carcinoma, Metastatic Malignant Neoplasm in the Lung | Phase 1 / Phase 2 | Recruiting | Stanford University | 30 | 2018-07-19 | 2026-10-05 |
| Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery Near-Infrared Fluorescence Imaging, Panitumumab, Panitumumab-IRDye800 - Malignant Brain Neoplasm, Malignant Glioma | Phase 1 / Phase 2 | Recruiting | Stanford University | 46 | 2018-05-16 | 2026-06-29 |
| Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery Fluorescence Imaging, Panitumumab, Panitumumab-IRDye800 - Pancreatic Adenocarcinoma | Phase 1 / Phase 2 | Recruiting | George Poultsides | 27 | 2018-02-07 | 2026-03-17 |
| Panitumumab IRDye800 Optical Imaging Study Panitumumab IRDye 800, da Vinci Firefly, IMAGE1 + ICG Hopkins telescope and/or VITOM - Head and Neck Cancer | Phase 1 | Completed | Eben Rosenthal | 64 | 2016-08-01 | 2021-09-24 |
Head and Neck Neoplasms (4) · Squamous Cell Carcinoma of Head and Neck (3) · Brain Neoplasms (1) · Carcinoma, Squamous Cell (1) · Glioma (1) · Laryngeal Diseases (1) · Lung Neoplasms (1) · Mouth Neoplasms (1) · Tongue Neoplasms (1)
Eben Rosenthal (2) · Stanford University (2) · Andrei Iagaru (1) · George Poultsides (1) · Vanderbilt-Ingram Cancer Center (1)
United States (7)
Eben L Rosenthal, MD (2) · Andrei Iagaru, MD (1) · Fred M Baik (1) · George Poultsides (1) · Lindsay Moore, MD (1) · Natalie Lui (1)
PMID 31421471, PMID 32416764, PMID 33078373, PMID 33168818, PMID 42289363
R01CA190306 (4), P30CA124435 (2)